UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Primecap Management Co. CA

Primecap Management Co. CA decreased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 88.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 12,920 shares of the healthcare conglomerate’s stock after selling 103,544 shares during the quarter. Primecap Management Co. CA’s holdings in UnitedHealth Group were worth $6,536,000 as of its most recent filing with the SEC.

A number of other large investors have also modified their holdings of UNH. Wallace Capital Management Inc. raised its holdings in shares of UnitedHealth Group by 0.9% during the third quarter. Wallace Capital Management Inc. now owns 2,119 shares of the healthcare conglomerate’s stock valued at $1,239,000 after buying an additional 19 shares during the last quarter. Western Pacific Wealth Management LP raised its stake in UnitedHealth Group by 2.2% during the 4th quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate’s stock valued at $456,000 after acquiring an additional 19 shares in the last quarter. MCF Advisors LLC increased its holdings in shares of UnitedHealth Group by 0.8% during the fourth quarter. MCF Advisors LLC now owns 2,578 shares of the healthcare conglomerate’s stock valued at $1,304,000 after purchasing an additional 20 shares during the period. Axiom Financial Strategies LLC lifted its holdings in UnitedHealth Group by 3.6% in the fourth quarter. Axiom Financial Strategies LLC now owns 575 shares of the healthcare conglomerate’s stock worth $291,000 after purchasing an additional 20 shares during the period. Finally, 44 Wealth Management LLC increased its stake in UnitedHealth Group by 1.6% during the 4th quarter. 44 Wealth Management LLC now owns 1,309 shares of the healthcare conglomerate’s stock valued at $662,000 after buying an additional 21 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on the stock. Wells Fargo & Company decreased their price objective on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Piper Sandler cut their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a report on Thursday, January 2nd. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Oppenheimer lifted their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. Finally, Truist Financial decreased their price target on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Twenty investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, UnitedHealth Group presently has a consensus rating of “Buy” and a consensus price target of $629.32.

Insiders Place Their Bets

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the purchase, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Down 0.1 %

UNH stock opened at $503.05 on Thursday. The company has a 50 day moving average of $510.48 and a two-hundred day moving average of $548.22. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The company has a market cap of $460.14 billion, a price-to-earnings ratio of 32.45, a PEG ratio of 1.37 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business’s revenue was up 6.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $5.83 EPS. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were paid a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.67%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s payout ratio is presently 54.19%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.